Uncertainty Over Availability of 10 Innovative Oncology Drugs in Serbia

A contract for 10 innovative oncology drugs was signed in April between Serbia's RFZO and AstraZeneca, but the exact start date for their implementation for patients remains unknown.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

danasCroatian14h ago

Kada će onkološkim bolesnicima u Srbiji biti dostupno 10 inovativnih lekova?

Republički fond za zdravstveno osiguranje (RFZO) potrpisao je ugovor sa kompanijom AstraZeneka o inovativnim lekovima namenjenim onkološkim bolesnicima u Srbiji početkom aprila, međutim, još uvek se ne zna kada će tačno krenuti primena tih lekova.

Read full article →

PERSPECTA

PERSPECTA

Uncertainty Over Availability of 10 Innovative Oncology Drugs in Serbia

Sources

Kada će onkološkim bolesnicima u Srbiji biti dostupno 10 inovativnih lekova?

Related Stories

Philippine Supreme Court Upholds Mental Illness as Grounds to Clear Mother of Parricide

Detained Contractor Curlee Discaya to Undergo Shoulder Surgery

PDEA agents arrest woman, seize P3.4-M shabu in Marawi drug sting

Nigerian Court Affirms FCCPC's Healthcare Oversight Powers

PERSPECTA